Helfie AI, a global mobile health platform, has been shortlisted for the prestigious Prix Galien USA 2025 prize for Best Digital Health Solution.
The company’s innovative approach in providing accessible, AI-powered health insights has earned it recognition as a leader in the digital health space.
Revolutionizing Healthcare Access and Monitoring
Helfie AI empowers individuals to monitor key health conditions, including cardiovascular, lung, sexual, and skin health, via their smartphones.
The platform delivers intelligent insights and continuous monitoring, making healthcare access possible for anyone, anywhere, at an affordable cost. Helfie AI’s solution eliminates barriers related to geography, income, and infrastructure.
The Vision Behind Helfie AI’s Success
CEO George Tomeski expressed pride in the nomination, emphasizing Helfie AI’s commitment to making preventative healthcare accessible to millions globally.
Helfie AI aims to transform healthcare from a series of isolated interactions into a continuous, ambient intelligence embedded in daily life, focusing on early disease detection and prevention.
Acknowledgment from Prix Galien Jury Chair
Kenneth C. Frazier, Jury Chair for the Prix Galien USA Awards, praised Helfie AI and other nominees for their groundbreaking work in digital health and medical technology. He highlighted the transformative potential of innovation in improving healthcare and enhancing lives.
Prix Galien USA Award Ceremony
The winners of the Prix Galien USA 2025 awards will be announced on October 30, 2025, during a ceremony at the American Museum of Natural History in New York City.
Helfie AI is among the leading contenders in the “Best Digital Health Solution” category, with its vision of democratizing healthcare through AI technology.
About The Prix Galien Awards
The Prix Galien Awards, established in 1970, are regarded as the equivalent of the Nobel Prize in biopharmaceutical research. The awards celebrate innovations in medicine and healthcare, with nominees selected for their contributions to improving human health.
Helfie AI’s Expanding Global Presence
Founded in Melbourne, Australia, in 2021, Helfie AI has expanded globally to Europe, North America, Africa, and Asia.
The company has established several active B2B partnerships and is focused on solving healthcare challenges by promoting participation in preventative care and better utilization of health data.
Tackling Preventable Healthcare Costs
Helfie AI’s accessibility and technology-driven approach aim to reduce the $7 trillion spent annually on preventable conditions.
By providing users with personalized health insights and connecting them to medical care when needed, Helfie AI is improving healthcare outcomes and reducing the financial burden of preventable illnesses.
